Hyaluronic Acid and the Skin Barrier: Humectant or Barrier Supporter?

What Is Hyaluronic Acid, and Where Is It Found in Skin?

Hyaluronic acid (HA) is a naturally occurring glycosaminoglycan polymer made of repeating N-acetylglucosamine and glucuronic acid units. The body contains roughly 15 grams of HA in total, most of it concentrated in the skin, synovial fluid, and vitreous humor of the eye.^[1] In skin specifically, HA is concentrated primarily in the dermis, near the basement membrane, and in the hair follicle sheath — but it's also meaningfully present in the epidermis, particularly in the granular and spinous layers.

Dermal HA is synthesized by fibroblasts via the HAS1, HAS2, and HAS3 enzymes; epidermal HA depends on keratinocyte HAS3 activity. Synthesis rate declines with age, and skin HA content drops noticeably — a decline that negatively affects both moisture capacity and barrier flexibility.^[2]

Why Molecular Weight Matters So Much

HA's different molecular weights (MW) serve distinct biological functions. High-MW HA (>1000 kDa) can't cross the stratum corneum due to its large chain structure; it forms a surface film that reduces transepidermal water loss (TEWL). Mid-MW HA (100-1000 kDa) partially penetrates the upper stratum corneum layers, providing intermediate hydration. Low-MW HA (<50 kDa) can reach living epidermis and, through interaction with the CD44 receptor, directly influences keratinocyte differentiation, tight junction protein expression, and inflammatory signaling.^[3]

Hyaluronic Acid and the Skin Barrier: The Mechanisms

Hyaluronic acid's effect on the skin barrier goes beyond simple physical moisture retention, working through several distinct biochemical pathways. Understanding these pathways is critical for predicting which HA formulation addresses which skin concern.

The CD44 Receptor and Barrier Signaling Pathway

The CD44 receptor on the keratinocyte surface is HA's primary cellular target. When low-MW HA binds CD44, expression of the tight junction proteins occludin and claudin-1 increases. These proteins form the "tight junction" layer between the stratum granulosum and spinosum, functioning as a second line of defense that blocks external agents — allergens, microorganisms, toxic substances — from reaching the dermal compartment.^[4]

Lamellar Body Secretion and the Lipid Barrier

Keratinocytes' lamellar bodies in the stratum granulosum secrete the lipids — ceramide, cholesterol, and free fatty acids — that form the stratum corneum. Research has shown HA can modulate this lamellar body secretion process and influence the activity of ceramide synthase enzymes involved in ceramide synthesis.^[5] This connection explains why hyaluronic acid, on its own, produces better barrier outcomes when combined with ceramide — a synergy that forms a core axis of modern dermocosmetic formulation.

Anti-Inflammatory Effect and Barrier Protection

High-MW HA blocks TLR2 and TLR4 receptors, suppressing pro-inflammatory cytokine release — a mechanism that contributes to reducing the chronic low-grade inflammation ("inflammaging") that triggers barrier damage.^[6] Low-MW HA fragments, on the other hand, can activate the NF-κB pathway when the barrier is damaged, contributing to inflammation — which is why oligomeric HA concentration and molecular-weight balance matter so much in formulation.

Hyaluronic Acid and TEWL Reduction: The Evidence in Numbers

"Transepidermal water loss (TEWL) is one of the most objective measures of barrier function. Controlled trials of multi-molecular-weight HA formulations have reported meaningful TEWL improvement relative to baseline after 8 weeks of use.^[7]"

Hyaluronic Acid, Ceramide, and Squalane: A Three-Way Synergy

However valuable hyaluronic acid is on its own, its real power in barrier repair emerges within multi-component formulations. In the barrier's "brick and mortar" model, HA supports keratinocyte (brick) integrity, while ceramide and cholesterol (mortar) stabilize the lipid matrix.

Combination With Ceramide

Ceramides make up roughly 50% of the stratum corneum's lipid matrix. When applied together with HA, the hydration environment HA provides facilitates the orderly arrangement of ceramide molecules within the lamellar structure. This synergy has been shown in clinical research to produce meaningful improvement in atopic dermatitis symptoms.

Combination With Squalane

Squalane is a hydrocarbon naturally present in skin's own sebum with excellent occlusive properties. Locking in the water HA provides requires an occlusive barrier layer — otherwise, in dry or windy environments, HA can pull moisture the other direction, dehydrating skin further. Squalane steps in here: it holds HA's bound water at the surface while, thanks to its non-oxidizing structure, also supporting the lipid barrier.

CIRÈLL's Biomimetic Approach

CIRÈLL's Biomimetic TriBarrier System was designed directly around this three-way synergy: multi-molecular-weight HA, a ceramide complex, and squalane are formulated together, targeting both immediate hydration and long-term barrier rebuilding.

Hyaluronic Acid's Role in Dehydrated and Damaged-Barrier Skin

Dehydrated skin means insufficient water content; barrier damage means disrupted lipid matrix integrity. These two conditions often occur together but require different interventions.

In dehydrated skin, HA's priority task is binding water and reducing TEWL — high-MW HA is the most effective form here. With barrier damage, the tight-junction rebuilding and ceramide-synthesis-supporting signaling pathways that low-MW HA activates via CD44 become more critical.

HA in Atopic Dermatitis and Eczema

Atopic dermatitis and eczema are characterized by primary barrier insufficiency linked to filaggrin mutation. In these patients, epidermal HA levels are low and CD44 expression is abnormally distributed. HA-containing emollients can reduce TEWL in these patients, breaking the itch-scratch cycle and potentially reducing corticosteroid need.^[8]

Application Order and Formulation Tips

Hyaluronic acid's effectiveness depends not just on its content but on how it's applied. Incorrect application — particularly in dry, low-humidity environments — can turn HA from beneficial to counterproductive.

What Your Skin Is Telling You

Hyaluronic acid deficiency or barrier dysfunction can present through several different signs — each one directly linked to one of HA's distinct mechanisms.

Conclusion

Hyaluronic acid has been positioned as a simple moisturizer for decades, but current science has clarified this molecule's genuinely multi-layered role in the skin barrier. Its high-MW form creates a surface moisture reservoir, while its low-MW form supports tight junction proteins and ceramide synthesis at the cellular level — both effects are necessary for a healthy barrier. In a single sentence: the answer to "humectant or barrier supporter?" is "both" — provided the right molecular weight, the right formulation, and the right application order come together. Using HA, ceramide, and squalane together in CIRÈLL products isn't a coincidence; the Biomimetic TriBarrier System puts this synergy on scientific footing, targeting both immediate hydration and long-term barrier repair.

Strengthening the Barrier With Hyaluronic Acid: Building a Personalized Care Routine

Once you understand hyaluronic acid's potential for supporting the skin barrier, it's time to adapt that knowledge to your daily routine. Barrier health isn't a universal concept — skin type, aging stage, climate conditions, and environmental exposure all directly affect HA's effectiveness. Dry and sensitive skin, for example, benefits more from higher-concentration hyaluronic acid serums, while for aging skin, combining HA with occlusive ingredients like ceramide and squalane becomes far more critical. A personalized approach doesn't just reduce moisture loss — it also supports skin's own repair mechanisms.

Those who use hyaluronic acid effectively for barrier support generally follow two core principles: concentration selection and seeking synergy. Low-molecular-weight hyaluronic acid (LMW-HA) at 0.5-1% concentrations achieves stronger dermal penetration than high-molecular-weight variants (HMW-HA) — but this can mean less content available to reinforce the epidermis. A more effective strategy is combining hyaluronic acid across different molecular weights to maximize both surface moisture retention and dermal hydration simultaneously. Application order and formulation choice can also sharply change HA's absorption and effect.

Finally, seasonal and dynamic barrier-support protocols are the key to long-term success. TEWL rises in winter, while summer sun exposure can damage collagen structure. Adjusting HA-containing formulations by season — adding occlusive layers in winter, preferring lighter serum formulations in summer — helps guarantee continuous barrier support. Consistent, regular TEWL-reduction interventions are relevant not just for acute dehydration but for preventing chronic barrier weakening over time.

Frequently Asked Questions

Further Reading